CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?
- 6 June 2002
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 180 (1) , 47-53
- https://doi.org/10.1016/s0304-3835(02)00019-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathwaysCancer, 2001
- Role of Exogenous and Endogenous Hormones in Endometrial CancerAnnals of the New York Academy of Sciences, 2001
- CYP19 gene polymorphism in endometrial cancer patientsZeitschrift für Krebsforschung und Klinische Onkologie, 2001
- Hormonal interactions in endometrial cancer.Endocrine-Related Cancer, 2000
- CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free womenCancer Letters, 2000
- Theories of Endometrial Carcinogenesis: A Multidisciplinary ApproachLaboratory Investigation, 2000
- Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17Human Molecular Genetics, 1994
- Estrogen and Endometrial Cancer: An Epilogue à la Recherche du Temps PerduGynecologic Oncology, 1994
- Cloning and Sequence of the Human Gene for P450cl7 (Steroid 17α-Hydroxylase/17,20 Lyase): Similarity with the Gene for P450c21DNA, 1987
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983